Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Younger age at melanoma diagnosis: a survey study of indoor tanning use.

Journal of the American Academy of Dermatology·2026
Same author

Prophylactic LYMphatic Reconstruction (LYMbR) to prevent lymphedema after node dissection for cutaneous malignancies: a randomized controlled trial.

Trials·2026
Same author

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.

Haematologica·2024
Same author

Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.

International journal of molecular sciences·2024
Same author

The effectiveness of video-based exercise training program for people with intellectual disability: a multicenter study.

Frontiers in sports and active living·2024
Same author

VEXAS syndrome: Vacuoles in myeloid, erythroid, and lymphoid lineages.

International journal of laboratory hematology·2023

Related Experiment Video

Updated: Mar 25, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K

Follicular Dendritic Cell Sarcoma.

Annie Wu1, Sheeja Pullarkat

  • 1From the Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

Archives of Pathology & Laboratory Medicine
|February 25, 2016
PubMed
Summary

Follicular dendritic cell sarcoma (FDCS) is a rare cancer. This review covers its key features, diagnostic challenges, and the crucial role of immunohistochemistry in identifying this distinctive tumor.

Area of Science:

  • Oncology
  • Pathology
  • Immunohistochemistry

Background:

  • Follicular dendritic cell sarcoma (FDCS) is an uncommon neoplastic proliferation.
  • It shares morphologic and immunophenotypic similarities with normal follicular dendritic cells.
  • While often originating in lymph nodes, a significant portion occurs in extranodal sites.

Purpose of the Study:

  • To review the pathogenesis, morphology, and clinical features of follicular dendritic cell sarcomas.
  • To highlight the diagnostic importance of immunophenotypic profiling.
  • To discuss the role of molecular studies, including BRAF mutations, in diagnosis.

Main Methods:

  • Review of existing literature on follicular dendritic cell sarcoma.
  • Analysis of histologic morphology and immunophenotypic profiles.

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.4K

Related Experiment Videos

Last Updated: Mar 25, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.4K
  • Inclusion of data on immunohistochemistry, electron microscopy, and clinical outcomes.

    • Main Results:

    • FDCS presents diagnostic challenges due to morphologic overlap with other tumors.
    • Immunophenotypic analysis is critical for accurate diagnosis.
    • Molecular studies, such as BRAF mutation analysis, can aid in diagnosis.

    Conclusions:

    • Accurate diagnosis of follicular dendritic cell sarcoma relies on a combination of morphologic and specific immunophenotypic features.
    • Understanding the clinical presentation, treatment, and prognosis is essential for patient management.
    • Further research into molecular alterations may enhance diagnostic capabilities.